A Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal Can
A phase 3 trial of Anlotinib, Bevacizumab, CAPOX in colorectal cancer, run by Chia Tai Tianqing Pharmaceutical Group Co., Ltd., active and no longer recruiting.
Overview
A Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal Cancer is a phase 3 interventional study registered as NCT04854668 by Chia Tai Tianqing Pharmaceutical Group Co., Ltd., with 748 participants enrolled, started 2021-05-27 and due to reach its primary completion in 2024-12-31. Interventions recorded: Anlotinib hydrochloride capsule, Bevacizumab, Oxaliplatin, Capecitabine. Conditions listed: Metastatic Colorectal Cancer. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialA Phase 2 Study of SSGJ-707 in Metastatic Colorectal Cancer Patients
Shares CAPOX (capecitabine, oxaliplatin), Capecitabine, Bevacizumab, Colorectal cancer.
- TrialClinical Trials of Benmelstobart Injection Combined With Anlotinib Hydrochloride Capsules in the Treatment of Advanced or Unresectable Alveolar Soft Part Sarcoma
Shares Anlotinib, Sino Biopharmaceutical (Chia Tai Tianqing).
- TrialA Phase Ib/II Trial of HS-20110 Combination Therapies in Advanced Colorectal Cancer Patients.
Shares Capecitabine, Bevacizumab, Colorectal cancer.
- TrialA Study of HDM2017 Combination Therapy in Advanced Colorectal Cancer
Shares CAPOX (capecitabine, oxaliplatin), Capecitabine, Bevacizumab, Colorectal cancer.
- TrialAnlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence.
Shares Anlotinib, Sino Biopharmaceutical (Chia Tai Tianqing).
- TrialA Clinical Study of SHR-A1811 in Combination With Chemotherapy and Bevacizumab Versus Standard Therapy as First-Line Treatment for Advanced Colorectal
Shares CAPOX (capecitabine, oxaliplatin), Bevacizumab, Colorectal cancer.
- TrialNeoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer
Shares CAPOX (capecitabine, oxaliplatin), Capecitabine, Colorectal cancer.
- TrialA Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard
Shares CAPOX (capecitabine, oxaliplatin), Bevacizumab, Colorectal cancer.